-
Most Popular
Uncategorized
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 147 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Can Ethereum Survive the Onslaught of Those Trying to Kill It?
Although many blockchain rivals have challenged the Ethereum throne, a total coup is probably unlikely given economic realities around ETH-USD.
What We Can Learn From the Theranos and WeWork Stories
Lying to investors, spending millions irresponsibly — the mistakes of WeWork and Theranos are glaring in hindsight. We can learn from them.
Rivian Stock Alert: Why Is RIVN Still Plunging Today?
Shares of Rivian stock have had a lackluster 2022 so far. A hawkish Fed and Amazon's collaboration with a competitor may be to blame.
These Will Be the Private Investing Winners and Losers for 2022
In 2022, expect to see some billion dollar private companies fail, and expect to see more ways that retail investors can participate.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 44 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Three Qualifiers Every Private Investment MUST Pass
We've all made costly, painful mistakes before. Learn how to avoid hurting yourself financially when assessing private investment ideas.
Private Space Investors Prepare for Windfalls
With several multi-billion dollar space companies all expanding their reach beyond the Earth, many private companies are worth looking at.
Is C3.ai Stock Finally a Buy After an 85% Decline From Post-IPO Highs?
C3.ai is a great company, but shares of AI stock have been decimated after falling 85% from the highs. Is it a buy after the dip?
SoftBank’s Faith in Money-Losing, High-Growth Coupang Will Be Rewarded
SoftBank Group borrowed to fund distributions using almost all of its $15-billion stake in Coupang and CPNG stock as collateral. Smart move.
These 10 Stocks Could Be the Market’s Biggest Winners in January
When investors sell their stocks at year-end, it has nothing to do with whether they like the company or if they believe a turnaround is coming. Instead, it has everything to do with taxes.
These Health-Tech Deals Highlight a Big Private Investing Trend
Most of Google's products have been built up by acquiring companies that fill its blind spots. Biotech companies are doing the same thing.
Upstart Holdings Is Destined To Revisit Its All-Time High
A return to $400 and beyond is the most probable outcome for UPST stock as this audacious fintech disruptor stands on firm financial ground.
Don’t Follow “Dumb Money” Into This Corner of the Crypto Market
Investment firms are pouring more money than ever into the blockchain, but those investments differ from traditional crypto in a key way.
The $7 TRILLION Self-Driving Revolution Is Here
For years, self-driving cars have been a mere science fiction concept with very rare on-road testing. Now, they’re ready to take over the world? What happened!? I’ll tell you what changed: The cost of LiDAR technology.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 89 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters
Genfit (GNFT) stock is rocketing higher on Friday after the company signed an exclusive licensing agreement with Ipsen (IPSEY).
What This Crypto Billionaire’s Big Bet on Longevity Means for You
Our lifespans have been on the rise for a century. The CEO of Coinbase is one person looking to expand our healthspans as well.
